Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
52.5M
-
Shares change
-
-3.63M
-
Total reported value, excl. options
-
$227M
-
Value change
-
-$23M
-
Put/Call ratio
-
3.16
-
Number of buys
-
91
-
Number of sells
-
-98
-
Price
-
$4.32
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2023
218 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.5M shares
of 58.9M outstanding shares and own 89.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.76M shares), VANGUARD GROUP INC (3.48M shares), RENAISSANCE TECHNOLOGIES LLC (3.27M shares), DIMENSIONAL FUND ADVISORS LP (2.16M shares), MILLENNIUM MANAGEMENT LLC (2.02M shares), D. E. Shaw & Co., Inc. (1.95M shares), ACADIAN ASSET MANAGEMENT LLC (1.75M shares), Pictet Asset Management Holding SA (1.74M shares), GOLDMAN SACHS GROUP INC (1.67M shares), and MORGAN STANLEY (1.59M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.